Purdue Sues Watson Over Generic OxyContin

Law360, New York (March 28, 2011, 1:35 PM EDT) -- Purdue Pharma LP is challenging a bid by Watson Pharmaceuticals Inc. and its subsidiaries to market a generic version of the painkiller OxyContin, launching lawsuits in Florida, New York state and Delaware.

With the three lawsuits filed Wednesday and Thursday, Purdue seeks to prevent Watson from making and selling a generic version of Oxycodone Hydrochloride Extended-Release tablets in the 10,15, 20, 30, 40, 60 and 80 milligram strengths. The drug is used to manage moderate to severe pain when a continuous opioid analgesic is needed for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.